GP Pharm is a private Spanish biopharmaceutical firm specializing in the development and production of injectable pharmaceutical products, with a particular focus on the fields of Oncology and Urology. Using cutting-edge technology based on Microspheres and Liposomes, GP Pharm is dedicated to bringing innovative drug delivery systems to the market. Their extensive range of products includes finished dose forms of peptides, nucleic acids, high potency drugs, and cytotoxics.

GP Pharm is committed to research and continuous innovation, investing in state-of-the-art technologies and employing a highly skilled team of experts. With a global presence and a focus on quality and regulatory compliance, GP Pharm has gained approval from various Regulatory Agencies worldwide. Additionally, GP Pharm offers Contract Manufacturing and Contract Development services to third parties, leveraging their extensive experience and modern manufacturing facilities.

The company also collaborates with international pharmaceutical companies to promote and distribute their portfolio products through licensing and supply agreements. GP Pharm's dedication to research, technology, and commercialization enables them to bring science to society and make a positive impact in the pharmaceutical industry